Between 6 and 22 June 1995, 8 patients in Kikwit, Democratic Republic of the Congo, who met the case definition used in Kikwit for Ebola (EBO) hemorrhagic fever, were transfused with blood donated by 5 convalescent patients. The donated blood contained IgG EBO antibodies but no EBO antigen. EBO antigens were detected in all the transfusion recipients just before transfusion. The 8 transfused patients had clinical symptoms similar to those of other EBO patients seen during the epidemic. All were seriously ill with severe asthenia, 4 presented with hemorrhagic manifestations, and 2 became comatose as their disease progressed. Only 1 transfused patient (12.5%) died; this number is significantly lower than the overall case fatality rate (80%) for the EBO epidemic in Kikwit and than the rates for other EBO epidemics. The reason for this low fatality rate remains to be explained. The transfused patients did receive better care than those in the initial phase of the epidemic. Plans should be made to prepare for a more thorough evaluation of passive immune therapy during a new EBO outbreak.
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Convalescent Blood as Treatment for EHF following days, her symptoms gradually disappeared. During Patient 1. A 27-year-old nurse had been involved in the her hospitalization, the girl also received infusions of a solution nursing care of 2 Italian nuns who died of EHF. She used protective clothing and gloves but may have touched her eyes of albumin, sodium chloride, and 10% and 50% glucose. Dur- JID 1999; 179 (Suppl 1) ing convalescence, she complained of arthralgia and myalgia, perature of 37.5ЊC; she did not have a conjunctival injection. The woman was treated with sodium chloride and glucose but by 21 June all of her symptoms had disappeared.
Patient 3. A 15-year-old girl had participated in the ritual infusions, papaverine, and vitamin B. While hospitalized, she developed epistaxis, cough with hemoptysis, dysphagia, and a funeral of her mother, who died of EBO on 27 May. On 2 June, the girl developed fever, chills, headache, vomiting, anorexia, slight degree of obnubilation. On 22 June, her temperature was 40ЊC, and she had intense asthenia, continued to vomit, asthenia, abdominal pain (mainly in the right hypochondrium), cough, and a conjunctival injection. On 9 June, the girl was complained of dysphagia, and developed dysuria. On 23 June, she was transfused with 250 cm 3 of blood. admitted to the hospital with the same complaints and with dysphagia and a temperature of 38ЊC. She was treated with
Her clinical condition rapidly improved, and the next day the diarrhea and the vomiting stopped. On 25 June, however, she paracetamol, chloroquine, and cotrimoxazole. By 12 June, most of her complaints had disappeared; however, the asthenia and had urinary incontinence, complained of photophobia and of arthralgia at the maxillo-mandibular joints, and she had diffifever persisted, and the conjunctival injection did not disappear until 14 June. On 15 June, she was transfused with 150 cm 3 culty opening her mouth. On 26 June, a painful swelling of the left parotic gland was noted. On 27 June, her temperature of blood. During her hospitalization, the girl also received infusions of a solution of albumin, 5% and 10% glucose, and returned to normal, and her clinical condition began to improve progressively. On 30 June, she was again able to open her sodium chloride. Two days later, her temperature was normal. She continued to complain of a slight headache for Ç1 month, mouth normally. During convalescence, the patient had several headaches. On 31 July, she was discharged from the hospital. and was discharged from the hospital on 24 July.
Patient 4.
A 54-year-old woman had been in contact with Patient 6. A 25-year-old woman, a daughter of patient 5, had been exposed to EBO virus under the same conditions a patient who died of EBO in the maternity ward of Kikwit II Hospital. She had eaten from the same plate as the EBO patient, as her mother. On 10 June, she developed chills, fever, nausea, headache, and anorexia, and a few days later, she develwashed her hands in the same bucket, and slept on the rug that had probably been soiled by diarrhea stools of the EBO patient.
oped diarrhea and severe asthenia. She was admitted to the hospital on 15 June, presenting with myalgia, arthralgia, waOne week later (4 June), she developed chills and fever. In the following days, she developed a headache, conjunctival tery diarrhea, vomiting, and severe asthenia. She also had a discrete conjunctival injection and was dehydrated, and injection, diarrhea, and vomiting.
She was admitted to the hospital on 11 June with complaints abdominal palpation was painful, mainly in the right hypochondrium. of severe asthenia, anorexia, generalized pain, dysphagia, fever, and diarrhea. A physical examination revealed a conjunctival
The woman was treated with atropine and metoclopramide. While hospitalized, she developed dysphagia, abdominal pain, injection and bleeding at an intravenous-injection site. She was treated with oral rehydration solution, quinine, intravenous callumbalgia, and arthralgia. On 19 June, she had decreased consciousness, anuria, and a high fever (40ЊC). She was treated cium, cotrimoxazole, and vitamin K. The patient also developed a cough and abdominal pain (mainly in the right hypowith ampicillin and quinine. On 23 June, she was confused, had severe asthenia, anorexia, lumbalgia, and trismus, and was chondrium). On 13 June, she was transfused with 250 cm 3 of blood. On 15 June, she still had serious asthenia, postprandial transfused with 250 cm 3 of blood. The day after transfusion, she was comatose, in shock, and had urinary incontinence. She vomiting, cough, dyspnea, and abdominal pain in the right hypochondrium. Her symptoms progressively disappeared was treated with infusions (5% glucose and Ringer lactate), and on 26 June, she began responding to questions but remained starting on 16 June. The patient complained of pain in her legs for 24 h. On 23 June, her temperature was normal; however, confused. On 29 June, her temperature was normal, and she was neurologically normal except for a slight degree of trismus. the fever reappeared on 26 June because of pneumonia. After 2 weeks of treatment with ampicillin, all her symptoms disapOn 1 July, she was able to walk, and on 4 July, she could open her mouth normally. During convalescence, the patient peared, and on 31 July, she was discharged from the hospital without any complaints.
complained of arthralgia of both knees and the left shoulder. On 31 July, she left the hospital without any complaints but Patient 5. A 44-year-old woman had cared for her daughter, who was hospitalized in a small clinic in Kikwit. A patient later developed uveitis.
Patient 7.
A 40-year-old woman had been in physical conwith EHF died in the bed next to her daughter. The woman had no direct contact with the EBO-infected person, but she tact with her nephew, who died of EHF. Her only contact was with his skin, due to a perforation in a glove she was wearing. had slept on a rug that had also been used by the EHF patient. The EHF patient had suffered from diarrhea and cough.
On 12 June, she developed abdominal pain, diarrhea, and dysphagia. On admission to the hospital on 15 June, she comOn 8 June, the woman developed headache, chills, asthenia, abdominal pain, and pain in her lower extremities, and on plained of chills, headache, diarrhea, dysphagia, asthenia, anorexia, dizziness, and arthralgia. A temperature of 38ЊC and a 12 June, she also developed diarrhea, anorexia, vomiting, and dizziness. She was admitted to the hospital on 15 June with discrete conjunctival injection were noted. She was treated with oral rehydration solution, paracetamol, quinine, dipyrone, and severe asthenia, bloody diarrhea, abdominal cramps, and a tem- S21 JID 1999; 179 (Suppl 1) Convalescent Blood as Treatment for EHF an infusion of 5% glucose. On 16 June, her temperature rePatient 8. A 48-year-old woman had been in physical contact with a friend who died of EHF. On 19 June, the turned to normal, but the diarrhea became very severe (up to 14 stools/day). She was treated with norofloxacine. On 21 June, woman developed chills, fever, headache, diarrhea, and dizziness. On 21 June, she was admitted to the hospital with her fever reappeared (39ЊC). The diarrhea had stopped, but she developed thoracic pain without cough (increasing at inspiradiarrhea (with 8 episodes of melena), vomiting, headache, severe asthenia, high fever (39ЊC), and discrete dysphagia. tion and not dependent on the position of the patient) and her appetite had improved slightly. On 23 June, she was transfused Bleeding and a hematoma were noted at an intravenous-injection site, and she had a conjunctival injection. On 22 June, with 450 cm 3 of blood. The next day she vomited 3 times, had developed a nonproductive cough, and continued to complain she was transfused with 400 cm 3 of blood and treated with vitamin K, sodium chloride, and 10% glucose infusions. On of dizziness. 24 June, she had a generalized epileptic seizure. She did not On 26 June, the patient complained of blurred vision, lumbalhave a fever, and she was treated with diazepam. Six hours gia, abdominal pain, anorexia, asthenia, and chills. On 27 June, later, she was found dead on the floor, next to her bed, with the patient had obnubilation, urinary incontinence, and tremors a hematoma on her face. of the extremities. On 28 June, she was comatose, and neck stiffness was noted. She was treated with ampicillin (12 g Evolution of EBO antigenemia and EBO IgG and IgM antibodies (table 3) . EBO antigens were detected in all transfuintravenously), dexamethasone (15 mg), plasma expander, albumin, sodium chloride, and 10% glucose. During the followsion recipients prior to transfusion. In 5 (83%) of 6 patients tested, EBO antigens had disappeared before day 4 after transing days, she progressively regained normal consciousness. On 2 July, she was neurologically normal but continued to suffer fusion. In 4 (57%) of 7 transfusion recipients tested, EBO IgG or IgM antibodies were present before transfusion (only 2 of from severe asthenia. During convalescence, the patient complained of headache and polyarthralgia. On 31 July, she was them had both IgG and IgM antibodies). After transfusion, IgG and IgM antibodies were detected in 7 (87.5%) of the 8 blood discharged from the hospital. because of the small number of patients studied and the lack of control subjects, we cannot conclude that the neutralizing who received blood transfusions from convalescent donors. This rate differs significantly from the overall case fatality rate antibodies in transfused convalescent blood improves the outcome for EHF patients. (80%) for the epidemic [2] and from the case fatality rates for other epidemics [3] . The reason for this lower case fatality rate Because the reservoir or vector of the EBO virus is not known, it is likely that in the future, there will be more EBO remains to be explained; however, it is known that the transfused patients received relatively better care (including infuepidemics of EHF. It is hoped that the lessons learned during the Kikwit outbreak will enable us to reduce case fatality rates. sions of glucose and electrolytes, treatment with antibiotic and antimalaria drugs, and food supplementation) than patients in Additional animal experiments with passive immune therapy are certainly needed; however, in the absence of an effective the early stage of the outbreak. Two other EHF patients who were treated in Europe also survived [11, 12] ; only 1 of them antiviral, plans should also be made to prepare for a more thorough evaluation of the efficacy of hyperimmune plasma received convalescent serum. However, 6 other EBO-infected patients (Italian nuns) in Kikwit who were treated with infutreatment during a new EBO virus outbreak. sions died.
Five other EBO patients (2 at the Mosango hospital and 3
